BGLC - BioNexus Gene Lab Corp
2.5
-0.080 -3.200%
Share volume: 5,706
Last Updated: 03-06-2026
Healthcare/Services – Health:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.58
-0.08
-0.03%
Summary score
37%
Profitability
36%
Dept financing
43%
Liquidity
61%
Performance
30%
Sector
Services
Industry
Healthcare/Services – Health
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-0.82%
Return on assets
-3.27%
Return on sales
-14.78%
Return on invested capital
10.83%
Total debt ratio
112.52%
Debt ratio change over timeo
-0.86%
Current Ratio
4.37%
Quick Ratio
3.59%
Cash Position Ratio
1.19%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-7.44%
Return on sales
-28.28%
Return on invested capital
0%
Total debt ratio
219.41%
Debt ratio change over timeo
0%
Current Ratio
6.25%
Quick Ratio
5.13%
Cash Position Ratio
1.2%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-8.66%
Return on sales
-27.62%
Return on invested capital
0%
Total debt ratio
237.98%
Debt ratio change over time
0%
Current Ratio
8.3%
Quick Ratio
6.81%
Cash Position Ratio
1.7%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.92%
Return on assets
-108.24%
Return on sales
-126.2%
Return on invested capital
-134.02%
Total debt ratio
-86.13%
Debt ratio change over time
-0.86%
Current Ratio
6.34%
Quick Ratio
3.14%
Cash Position Ratio
0.1%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BGLC | HCA | NTRA | LH |
|---|---|---|---|---|
| Return on equity | -0.82% | -67.44% | -21.92% | 0% |
| Return on assets | -3.27% | 4.71% | -7.64% | 1.82% |
| Return on sales | -14.78% | 15.68% | -38.74% | 9.64% |
| Return on invested capital | 10.83% | 4.62% | 136.19% | 0% |
| Profitability | 2% | 51% | 25% | 50% |
| Total debt ratio | 112.52% | 104.82% | 44.97% | 53.61% |
| Debt ratio change over time | -0.86% | 20.97% | -0.6% | 0% |
| Dept financing | 25% | 48% | 10% | 12% |
| Current Ratio | 6.25% | 1.03% | 3.72% | 1.58% |
| Quick Ratio | 5.13% | 0.91% | 3.58% | 1.39% |
| Cash Position Ratio | 1.2% | 0.08% | 2.59% | 0.28% |
| Liquididy | 59% | 15% | 73% | 21% |
| Short-term ratios | BGLC | HCA | NTRA | LH |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -7.44% | 4.8% | -5.03% | 1.82% |
| Return on sales | -28.28% | 15.4% | -16.51% | 9.64% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 0% | 25% |
| Total debt ratio | 219.41% | 106.6% | 29.2% | 53.61% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 12% | 3% | 6% |
| Current Ratio | 6.25% | 1.03% | 3.72% | 1.58% |
| Quick Ratio | 5.13% | 0.91% | 3.58% | 1.39% |
| Cash Position Ratio | 1.2% | 0.08% | 2.59% | 0.28% |
| Liquididy | 62% | 9% | 57% | 16% |